Elisabeth Bjork

Insider Reports History

Location
New York, NY
Signature
/s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elisabeth Bjork:

Company Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Director Common Stock 50,000 $172,000 $3.44 02 Jan 2026 Direct

Insider Reports Filed by Elisabeth Bjork

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RCKT ROCKET PHARMACEUTICALS, INC. 02 Jan 2026 1 +$34,400 4 Director 06 Jan 2026, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 27 Aug 2025 1 +$34,100 4 Director 27 Aug 2025, 20:54
RCKT ROCKET PHARMACEUTICALS, INC. 18 Jun 2025 1 $0 4 Director 18 Jul 2025, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 26 Sep 2024 1 $0 4 Director 29 Oct 2024, 17:05
RCKT ROCKET PHARMACEUTICALS, INC. 13 Jun 2024 2 +$50,008 4 Director 20 Jun 2024, 16:10
RCKT ROCKET PHARMACEUTICALS, INC. 22 Jun 2023 2 +$50,009 4 Director 26 Jun 2023, 19:47
RCKT ROCKET PHARMACEUTICALS, INC. 13 Jun 2022 2 +$49,946 4 Director 15 Jun 2022, 21:07
RCKT ROCKET PHARMACEUTICALS, INC. 14 Jun 2021 2 +$49,985 4 Director 16 Jun 2021, 19:55